mobile header
telelphone

Overview

image

Larynx forms a section of the respiratory system and is located at the front of the esophagus. Its functions include breathing, speaking, and swallowing. It is divided into three parts, i.e., supraglottic, glottis, and subglottis. Mutation in the cells of any of the sections results in laryngeal cancer.

Taking On Cancer, Together !​

Life does not stop when cancer strikes.​

We are with you in this fight to win over cancer. We are here to give you the strength to recover through a comprehensive cancer care program.

Request an Appointment
Life Does Not Support

Frequently Asked Questions (FAQs)

Diagnosis at American Oncology Institute involves a combination of clinical evaluation, laryngoscopy, imaging tests such as CT or MRI scans, and biopsy to confirm the presence and stage of laryngeal cancer.

While not all cases are preventable, avoiding smoking, limiting alcohol, practicing good oral hygiene, and seeking early medical advice for persistent throat issues significantly lowers the risk of laryngeal cancer.

Patients can consult experienced oncologists for personalized laryngeal cancer care by calling the AOI helpline at 1800 208 2000 or booking an appointment online at https://www.americanoncology.com/bookanappointment

Laryngeal cancer is a type of head and neck cancer that begins in the tissues of the larynx (voice box), often linked to tobacco use, alcohol consumption, and other risk factors. At American Oncology Institute, specialists provide advanced diagnostic and treatment approaches tailored to each patient.

The most common symptoms include persistent hoarseness, sore throat, difficulty swallowing, ear pain, or a lump in the neck, and early evaluation at AOI helps in timely detection and better outcomes.

Treatment options for laryngeal cancer at AOI include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination depending on the stage and location of the tumor, with an emphasis on preserving voice and swallowing functions.

The survival rate depends on the stage at diagnosis, overall health of the patient, and timely treatment, and with advanced therapies at American Oncology Institute, many patients achieve favorable outcomes.